At the news
? NEUTRALIMPACT 3/10 SC 13G filed Nov 10, 2026 at 09:15 ET
State Street Corp filed a Schedule 13G disclosing a 5.1% passive beneficial ownership stake in SELLAS Life Sciences Group as of September 30, 2026, representing 10,373,074 shares. This is an amendment to a prior 13G filing from August 2026, indicating a continued passive position with no intent to influence control.
- State Street Corp disclosed a 5.1% passive beneficial ownership stake in SELLAS Life Sciences Group
- Stake consists of 10,373,074 shares of common stock as of September 30, 2026
- Filing is an amendment to a prior Schedule 13G filed on August 7, 2026
- State Street certifies the securities were acquired and held in the ordinary course of business with no intent to influence control
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access